William Blair analysts project AbbVie to earn $16.15 per share by FY2028, a notable jump from its current $12.31 estimate.

Qualcomm stock gained 28.2% in three months, outperforming some rivals but trailing others. Qualcomm’s Snapdragon 8 Elite ...

Mastercard remains a titan in the booming $3 trillion digital payments market, with innovations and global expansion fueling ...

Novem Group ramped up its Southern Copper stake by 34.4% in the first quarter, showing clear bullish confidence in the mining ...

Riverview Trust slightly reduced its Microsoft stake but still considers it a top holding worth over $3.8 million. Insider ...

Retirement Planning Group LLC shaved a minuscule 0.1% off its Apple holdings in Q1, selling just 72 shares—hardly ...

Nvidia surged toward becoming the most valuable company in history, briefly topping a $3.92 trillion valuation on Thursday.

Precedent Wealth Partners LLC reduced its Amazon holdings by 3.9% in Q1, selling 227 shares worth about $1,075,000. Other ...

Tech CEOs warn of AI job cuts, but ironically, the few building AI are cashing in. Meta is showering millions on top AI ...

Truist Financial has reiterated its “buy” rating for Alphabet with a bold $200 price target, signaling confidence in the tech ...

UBS remains bullish on Eli Lilly’s future thanks to surging demand for its obesity and diabetes treatments. UBS predicts Zepbound sales could exceed market expectations by roughly 15%. Meanwhile, ...

Confluence Wealth Services grew its Visa stake by 6% in the first quarter, reaching $6.9 million across 20,750 shares. Visa ...